Regeneron Pharmaceuticals, Inc.

NEW YORK STATE COMMON RETIREMENT FUND REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

117,369

Value ($000)

90,594

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	90,594	0.1%	117,369	12/31/2025
2025 Q3	11/3/2025	67,792	0.1%	120,569	9/30/2025
2025 Q2	10/8/2025	67,236	0.1%	128,069	6/30/2025
2025 Q1	10/8/2025	82,792	0.1%	130,540	3/31/2025
2024 Q4	10/8/2025	97,864	0.1%	137,386	12/31/2024
2024 Q3	10/8/2025	144,426	0.2%	137,386	9/30/2024
2024 Q2	10/8/2025	154,454	0.2%	146,955	6/30/2024
2024 Q1	10/8/2025	140,442	0.2%	145,915	3/31/2024
2023 Q4	10/8/2025	131,917	0.2%	150,198	12/31/2023
2023 Q3	10/8/2025	133,598	0.2%	162,338	9/30/2023
2023 Q2	10/8/2025	122,279	0.2%	170,177	6/30/2023
2023 Q1	10/8/2025	145,085	0.2%	176,573	3/31/2023
2022 Q4	10/8/2025	133,815	0.2%	185,470	12/31/2022
2022 Q3	11/8/2022	127,733	0.2%	185,424	9/30/2022
2022 Q2	8/4/2022	114,868	0.1%	194,320	6/30/2022
2022 Q1	7/1/2022	139,940	0.1%	200,366	3/31/2022
2021 Q4	2/2/2022	123,940	0.1%	196,256	12/31/2021
2021 Q3	11/2/2021	119,891	0.1%	198,108	9/30/2021
2021 Q2	8/2/2021	112,534	0.1%	201,478	6/30/2021
2021 Q1	5/11/2021	90,576	0.1%	191,436	3/31/2021
2020 Q4	2/8/2021	93,398	0.1%	193,326	12/31/2020
2020 Q3	11/5/2020	113,650	0.1%	203,026	9/30/2020
2020 Q2	8/7/2020	132,468	0.2%	212,407	6/30/2020
2020 Q1	5/6/2020	92,940	0.1%	190,337	3/31/2020
2019 Q4	2/5/2020	72,081	0.1%	191,971	12/31/2019
2014 Q2	8/5/2014	64,841	0.1%	229,549	6/30/2014
2014 Q1	5/5/2014	66,925	0.1%	222,874	3/31/2014
2013 Q4	2/7/2014	61,874	0.1%	224,799	12/31/2013